Pinnacle Associates LTD Cara Therapeutics, Inc. Transaction History

Pinnacle Associates LTD

$6.17 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$0.6 - $1.65 $382,515 - $1.05 Million	-637,526 Reduced 98.19%	11,727 $8,000
Q3 2023 Oct 23, 2023	SELL	$1.67 - $3.33 $38,722 - $77,212	-23,187 Reduced 3.45%	649,253 $1.09 Million
Q2 2023 Jul 26, 2023	SELL	$2.83 - $4.94 $19,733 - $34,446	-6,973 Reduced 1.03%	672,440 $1.9 Million
Q1 2023 May 04, 2023	SELL	$4.89 - $12.27 $41,428 - $103,951	-8,472 Reduced 1.23%	679,413 $3.34 Million
Q4 2022 Jan 31, 2023	SELL	$8.88 - $12.77 $202,526 - $291,245	-22,807 Reduced 3.21%	687,885 $7.39 Million

Q4 2022 Jan 25, 2023	BUY	$8.88 - $12.77 $47,286 - $68,000	5,325 Added 0.75%	710,692 $0
Q3 2022 Oct 31, 2022	SELL	$8.24 - $12.56 $307,689 - $469,002	-37,341 Reduced 5.03%	705,367 $6.6 Million
Q2 2022 Aug 02, 2022	BUY	$7.45 - $13.84 $19,384 - $36,011	2,602 Added 0.35%	742,708 $6.78 Million
Q1 2022 May 05, 2022	BUY	$9.94 - $12.65 $3.55 Million - $4.52 Million	357,628 Added 93.5%	740,106 $8.99 Million
Q4 2021 Feb 02, 2022	BUY	$11.99 - $18.14 $522,236 - $790,105	43,556 Added 12.85%	382,478 $4.66 Million
Q3 2021 Oct 19, 2021	SELL	$11.55 - $16.06 $123,238 - $171,360	-10,670 Reduced 3.05%	338,922 $5.24 Million
Q2 2021 Aug 02, 2021	BUY	$12.38 - $29.19 $61,169 - $144,227	4,941 Added 1.43%	349,592 $4.99 Million
Q1 2021 May 12, 2021	SELL	$15.07 - $21.71 $428,364 - $617,106	-28,425 Reduced 7.62%	344,651 $7.48 Million
Q4 2020 Jan 26, 2021	SELL	$12.72 - $16.16 $357,152 - $453,740	-28,078 Reduced 7.0%	373,076 $5.65 Million
Q3 2020 Oct 23, 2020	SELL	$12.34 - $17.92 $147,672 - $214,448	-11,967 Reduced 2.9%	401,154 $5.11 Million
Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $60,091 - $84,050	-4,850 Reduced 1.16%	413,121 $7.06 Million
Q1 2020 May 13, 2020	SELL	$9.12 - $17.78 $437,112 - $852,177	-47,929 Reduced 10.29%	417,971 $5.52 Million
Q4 2019 Feb 03, 2020	BUY	$16.11 - $25.98 $1.9 Million - $3.07 Million	118,025 Added 33.93%	465,900 $7.51 Million
Q3 2019 Nov 08, 2019	BUY	$18.28 - $26.91 $6.36 Million - $9.36 Million	347,875 New	347,875 $6.36 Million

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$1.13 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$818,815
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$598,969
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$561,696
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$513,562
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account